Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems

Wellpro 384 from Thermo Scientific

Clamps from Thermo Scientific

Scotch-Brite pads from Thermo Scientific

Multidrop DW (Deep Well) (220-240 V) from Thermo Scientific

Wellpro 384 from Thermo Scientific Clamps from Thermo Scientific Scotch-Brite pads from Thermo Scientific Multidrop DW (Deep Well) (220-240 V) from Thermo Scientific

(Date:11/4/2009)...fic corridors in the cities of Long Beach and Rive... of preventable childhood asthma, and the true imp...ease has likely been underestimated, according to ...ia (USC). , The study, which appears in an onli...th , estimated that nine percent of all childhood ...

(Date:11/4/2009)... BC - Lowly bacteria, it turns out, hold the power...ants around the world clean up toxic waste on test...cally RDX, were invented back in World War II and ... These high-energy compounds are often used to pro...on of TNT. , But with increased knowledge of t...

(Date:11/4/2009)...sity of Oklahoma at Norman has received more than ...gencies as part of the federal stimulus program, b...ed by OU researchers to $23 million. Thirty-three...nging from archaeology to weather. , "The univer...oach to matching areasof scholarly excellence to f...

Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2 Genomic research will enable greener cleanup of military explosive test sites 2 OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2 OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3 Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 1 Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 2 Cell Protein Could Help Spur Malignancy 50101 1 Cell Protein Could Help Spur Malignancy 50101 2 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 1 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 2 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 3 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 4

[0] USC study finds big air pollution impacts on local communities [0] Genomic research will enable greener cleanup of military explosive test sites [0] OU achieves $10 million in stimulus grants for 33 projects on the Norman campus

...OLIS / ST. PAUL (Jan. 8, 2008) Adolescent girls w... less likely to use diet pills, laxatives, or othe...ars later, according to research led by Dianne Neu...tor of Project Eating Among Teens (Project EAT) at...th. , Neumark-Sztainer and Project EAT colleagues...

...lphia, PA, January 8, 2008 Schizophrenia is a dev... contributing to increased risk. Available antips...schizophrenia, but are typically effective in only...cult to predict the effectiveness of a specific dr...hn H. Krystal, M.D., Editor of Biological Psychiat...

...ter Joins Olive, Edwards & Cooper with Technical, ...ound, WASHINGTON, Jan. 7 Today, Olive, Edwards &...ter as a principal who will,provide clients with s...meland security marketplace. His immediate focus w...dgeable about the SAFETY Act (the Support,Anti-Ter...

Other Biology News:U of M research finds disordered eating less common among teen girls who regularly eat family meals 2 Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity 2 Chemist Brings SAFETY Act Expertise to Homeland Security Firm 2

U of M research finds disordered eating less common among teen girls who regularly eat family meals Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity Chemist Brings SAFETY Act Expertise to Homeland Security Firm

(Date:11/6/2009)...tCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:...ced updated results from a Phase II study of intra...tatic to the lung in a poster presentation at the ...ting held in Miami Beach, Florida, from November 5...ase II Study of Intravenous REOLYSIN (Wild-type Re...

(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...

(Date:11/5/2009)...PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasd...ucts for processing and storing adult stem cells, ...scal 2010. ,, For the quarter ended September 3...lion, a 15 percent increase over revenues of $4.5 ...ny said the key contributors to the growth in reve...

(Date:11/5/2009)...swire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today... the following investor conferences, and invited i... Credit Suisse Healthcare Conference, Phoeni... at 10 a.m. Mountain Time, NASDAQ... Tuesday, 1 December, 2009 at 10.45 a.m....

Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2 Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3 GenVec Reports Third Quarter 2009 Financial Results 2 GenVec Reports Third Quarter 2009 Financial Results 3 GenVec Reports Third Quarter 2009 Financial Results 4 GenVec Reports Third Quarter 2009 Financial Results 5 GenVec Reports Third Quarter 2009 Financial Results 6 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7 ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8 Cepheid to Webcast Upcoming Financial Presentations 2

[0] Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting [0] GenVec Reports Third Quarter 2009 Financial Results [0] ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line [0] Cepheid to Webcast Upcoming Financial Presentations

Products	Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Company	R&D Systems
Item	Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated
Price	$380.00
Description	Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb
Info	R&D Systems R&D Systems, Inc. 614 McKinley Place N.E. Minneapolis, MN 55413 Customer Service: 1 (800) 343-7475 1 (612) 379-2956 Fax Number: 1 (612) 656-4400 Web Site: http://www.rndsystems.com